期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

宫颈癌组织端粒酶活性与HPV感染的关系 被引量：1

The relation between telomerase activity and human papillomavirus infection in cervical cancer
暂未订购
导出
摘要 目的探讨宫颈癌组织端粒酶活性与人乳头状瘤病毒(HPV)感染的关系。方法采用原位PCR和原位杂交技术对66例宫颈癌和25例宫颈上皮内瘤变(CIN)组织进行检测。结果宫颈癌组织中端粒酶阳性率为92.4%(61/66),明显高于CIN的32.0%(χ2=33.24,P<0.001)。宫颈癌组织中HPVDNA阳性率为78.8%(52/66),52例HPVDNA阳性组织中51(98.1%)例端粒酶阳性(χ2=11.188,P<0.001)。结论端粒酶活性与HPV感染有密切关系。HPV感染在宫颈癌发生中可能有病因学意义,端粒酶活性增强可能是宫颈癌转化中的重要分子变化。 Objective To study the relation between telomerase activity and human papillomavirus(HPV)infection in cervical cancer.Methods In situ hybridization and in situ PCR were used to detected the telomerase activity and HPV DNA in66cases of cervical cancer and in25cases of cervical intraepithial neoplasia (CIN).Results The rate of telomerases positive expression in cervical cancer was92.4%(61/66).It was significantly higher than that in the CIN (χ 2 =33.24,P<0.001).HPV positive rate was78.8%(52/66)in cervical cancer,of which telomerases of51(98.1%)cases is positive(χ 2 =11.188,P<0.001).Conclusion There is a close relationship of the HPV infection and telomerases activity.HPV infection might have etiologic significance for cervical cancer.The high telomerases activity could be a marker of biomolecular change in cervical cancer.
作者 李西启 张玲 徐廷香 王剑波
机构地区 [ 第四军医大学
出处 《实用医药杂志》 2003年第10期758-759,共2页 Practical Journal of Medicine & Pharmacy
关键词 宫颈肿瘤 端粒酶 人乳头状瘤病毒(HPV) Cervical neoplasm Telomerase Human papillomavirus(HPV)
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献10

  • 1Counter CM, Hirte HW, Bacchetti S, et al. Telomerase activity in human ovarian cancer. Proc Natl Acad Sci USA, 1994,91 (12):2900
  • 2Blackburn ER. Telomerase:no end in sight. Cell, 1994,7(4):621
  • 3Ohta Y, Tsutsumi K, Kikuchi K, et al. Two dististinct human uterine cervical epithelial cell lines established after infection with human papilomavirus 16 DNA. Jpn J Cancer Res, 1997,88(7):644
  • 4李西启,徐廷香,王剑波,赵秀娥,王涛,杨怀芳.应用原位PCR技术检测宫颈癌和宫颈上皮内瘤变组织中人乳头瘤病毒DNA[J].前卫医药杂志,2001,18(5):326-327. 被引量：1
  • 5Ramakrishnan S,Roche H,Nutey I,et al. Expression profile of the utative catalytic of the telomerase gene. Cancer Res,1998,589(4):622
  • 6Pao CC,Tsen CJ,Lin CY,et al. Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasia lesions. J Clin Oncol,1997,15(11):1932
  • 7Zhang DK,Nagan HY, Cheng RY, et al. Clinical significance of telomerase activation and telomeric restriction fragment in cervical cancer. Eur J Cancer, 1999,35(1):154
  • 8Nagai N, Oshita T, Murakami J, et al. Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions.Oncol Pep, 1999,6(2):325
  • 9Aloysius J, Klingelhutz , Scott A. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature, 1996,380(7):79
  • 10Anderson S,Shera K,Ihle J,et al.Telomerase activation in cervical cancer. Am J Pathol, 1997,151(1):25

二级参考文献7

  • 1Haast AT, Betzel EF, Staskus KA. Amplification and detection of lentiviral DNA inside cell. Proc Natl Acad Sci USA, 1990,87: 4971
  • 2Herrington CS. Human papillomaviruses and cervical neoplasia, Ⅱ ,interaction of HPV with other factors. J Clin Pathol, 1995,48:1
  • 3Nuovo GH. PCR in situ hybridization. Protocols and amplicatings. Raven Press, New York, 1992:185
  • 4Nuovo GJ, Gallery F, Maccomell P, et al. An improved technique for the in situ detection of DNA after polymerase chain reaction amplification. Am J Pathol, 1991,139:1239
  • 5Nuovo GJ,Conell PM, Fords A, et al. Detection of human papillomavirus DNA in formalin fixed tissue by in situ hybridization after amplification by polymerase chain reaction. Am J Pathol, 1991,139:847
  • 6Nuovo GJ,Becker J, Margiotta M, et al. Histological distribution of polymerase chain reaction amplified human papillomavirus 6 and 11DNA in penile lesions. Am J Surg Pathol, 1992,160: 269
  • 7Gu J. Principles and amplifications of in situ PCR. Cell Vision,1994,1: 8

同被引文献21

  • 1Richart RM.Causes and management of cervical intraepithelial neoplasia[J]. Cancer, 1987,60:1951-1959.
  • 2Syrjanen KJ. Natural history of genital papillomavirus infections[A]. In: Lacey C. Papillomavirus Reviews: Current Research on papillomaviruses.[C]. Leeds: Leeds University Press, 1996. 189-206.
  • 3Ostor AG. The natural history of cervical intraepithelial neoplasia: a critical review[J]. Int J Gynecol Pathol, 1993,12: 186-192.
  • 4Robertson AJ,Anderson JM, Beck JS, et al. Observer variability in histopathological reporting of cervical biopsy specimens[J]. J Clin Pathol, 1989,42:231-238.
  • 5Ismail SM, Colclough AB, Dinnen JS, et al. Reporting cervical intraepithelial neoplasia(CIN): intra and inter-pathologist variation and factors associated with disagreement[J]. Histopathology,1990,16:371-376.
  • 6Walboomers M, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide[J]. J Pathol,1999,189:1-3.
  • 7Dyson NJ. The regulation of E2F by Rb-family proteins[J]. Genes Dev, 1998,12:2245-2265.
  • 8Von Knebel Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections[J]. Eur J Cancer, 2002,38:2229-2242.
  • 9Southern SA, Herrington CS. Disruption of cell cycle by human papillomaviruses with special reference to cervical carcinoma[J]. Int J Gynecol Cancer, 2000,10:263-274.
  • 10Klaes R, Benner A, Friedrich T, et al. P16ink4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia[J]. Am J Surgical Pathol, 2002, 26(11):1389-1399.

引证文献1

实用医药杂志
2003年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部